News Archive

/static/apps/cms/news/1639/Natalie Farwell 500.jpg

Enhancing Heart Failure Patient Care with the MOS Dashboard

June 3, 2025 / Dqhi

Heart failure with reduced ejection fraction (HFrEF), which measures your heart’s ability to pump oxygen-rich blood out to your body, remains a leading cause of death and hospitalization worldwide. Over the last three decades, clinical trials have highlighted the efficacy of four key medication classes- Beta-blockers, angiotensin-converting enzyme inhibitors (ACEis), angiotensin receptor-neprilysin inhibitors (ARNI), and sodium-glucose cotransporter 2 inhibitors (SGLT2i). Together, these medications form the pillars of guideline-directed medical therapy (GDMT), which has significantly improved patient outcomes, contributing to up to a 70% reduction in mortality among HFrEF patients.

FULL STORY
/static/apps/cms/news/1637/images/banners/TPTR Retreat fun pose.png

Translational Research Training Program Retreat

June 2, 2025 / Phd Program

A fascinating glimpse into cutting-edge research

FULL STORY